MoneyWorks4Me

Dr. Lal PathLabs informs about analyst meet

20 Sep 2021 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal PathLabs has informed that the details of proposed schedule of Analyst/ Institutional Investor meeting(s) is attached.

The above information is a part of company’s filings submitted to BSE.

Peers